Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Read more about Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial. Read more about Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.
Electronic cigarettes and smoking cessation: a quandary? Read more about Electronic cigarettes and smoking cessation: a quandary?
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Read more about Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.
Genetics and biomarkers in personalisation of lung cancer treatment. Read more about Genetics and biomarkers in personalisation of lung cancer treatment.
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Read more about Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.
Inequalities in non-communicable diseases and effective responses. Read more about Inequalities in non-communicable diseases and effective responses.
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Read more about Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Read more about Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Breast and cervical cancer in 187 countries between 1980 and 2010. Read more about Breast and cervical cancer in 187 countries between 1980 and 2010.
